The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
Open accessAbstract
Metastasis, the dissemination and growth of neoplastic cells in an organ distinct from that in which they originated, is the most common cause of death in cancer patients. This is particularly true for pancreatic cancers, where most patients are diagnosed with metastatic disease and few show a sustained response to chemotherapy or radiation therapy. Whether the dismal prognosis of patients with pancreatic cancer compared to patients with other types of cancer is a result of late diagnosis or early dissemination of disease to distant organs is not known. Here we rely on data generated by sequencing the genomes of seven pancreatic cancer metastases to evaluate the clonal relationships among primary and metastatic cancers. We find that clonal populations that give rise to distant metastases are represented within the primary carcinoma, but these clones are genetically evolved from the original parental, non-metastatic clone. Thus, genetic heterogeneity of metastases reflects that within the primary carcinoma. A quantitative analysis of the timing of the genetic evolution of pancreatic cancer was performed, indicating at least a decade between the occurrence of the initiating mutation and the birth of the parental, non-metastatic founder cell. At least five more years are required for the acquisition of metastatic ability and patients die an average of two years thereafter. These data provide novel insights into the genetic features underlying pancreatic cancer progression and define a broad time window of opportunity for early detection to prevent deaths from metastatic disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“modeling studies performed on the mutational data have estimated that the timeline of multistep progression to invasive neoplasia in the pancreas likely spans multiple years and provides a theoretically wide window of opportunity for early detection27.”
From Pancreatic cancer: Advances and challenges (2023) · cites this paper as [27]
In the citing paper
“Pancreatic tumours are highly heterogeneous, both within and between individuals.66,67”
From Early detection of pancreatic cancer (2020) · cites this paper as [67]
In the citing paper
“It is now appreciated that most clinically relevant solid tumors are highly heterogeneous at the phenotypic, physiologic, and genomic levels (13–15) and that they continue to evolve over time.”
From Radiomics: Images Are More than Pictures, They Are Data (2016) · cites this paper as [13]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Spencer, P. M., Cameron, J. L., & Lin, L. (2000) · Cited by 7,202
Genetic instabilities in human cancers
Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1998) · Nature · doi:10.1038/25292 · Cited by 4,168
Self-citationCore Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
Jones, S., Zhang, X., Parsons, D. W., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Kamiyama, H., Jimeno, A., et al. (2008) · Science · doi:10.1126/science.1164368 · Cited by 3,969
Self-citationOlive, K. P., Jacobetz, M. A., Davidson, C. J., Gopinathan, A., McIntyre, D., Honess, D., Madhu, B., Goldgraben, M. A., Caldwell, M. E., Allard, D., et al. (2009) · Science · doi:10.1126/science.1171362 · Cited by 3,170
Self-citationMetastasis: from dissemination to organ-specific colonization
Nguyen, D. X., Bos, P. D., & Massagué, J. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2622 · Cited by 2,716
Isaacson, P. G., Doǧan, A., Price, S. K., & Spencer, J. (1989) · The American Journal of Surgical Pathology · doi:10.1097/00000478-198912000-00004 · Cited by 1,913
Comparative lesion sequencing provides insights into tumor evolution
Jones, S., Chen, W.-D. D., Parmigiani, G., Diehl, F., Beerenwinkel, N., Tibor Antal, A., Traulsen, A., Nowak, M. A., Siegel, C., Velculescu, V. E., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712345105 · Cited by 827
Self-citationAdvanced pancreatic carcinoma: current treatment and future challenges
Stathis, A., & Moore, M. J. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2009.236 · Cited by 791
Signatures of mutation and selection in the cancer genome
Bignell, G. R., Greenman, C. D., Davies, H., Butler, A. P., Edkins, S., Andrews, J. M., Buck, G., Chen, L., Beare, D., Latimer, C., et al. (2010) · Nature · doi:10.1038/nature08768 · Cited by 707
Self-citationMaitra, A., & Hruban, R. H. (2008) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathmechdis.3.121806.154305 · Cited by 707
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 401–500 of 1,006
Effects of Astaxanthin on the Proliferation and Migration of Breast Cancer Cells In Vitro
McCall, B. J., McPartland, C. K., Moore, R. A., Frank‐Kamenetskii, A., & Booth, B. W. (2018) · Antioxidants · doi:10.3390/antiox7100135 · Cited by 116
Spatial mapping of transcriptomic plasticity in metastatic pancreatic cancer
Pei, G., Min, J., Rajapakshe, K., Branchi, V., Liu, Y., Selvanesan, B. C., Thege, F. I., Sadeghian, D., Zhang, D., Cho, K. S., et al. (2025) · Nature · doi:10.1038/s41586-025-08927-x · Cited by 121
Makawita, S., Smith, C. R., Batruch, I., Zheng, Y., Rückert, F., Grützmann, R., Pilarsky, C. P., Gallinger, S., & Diamandis, E. P. (2011) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.008599 · Cited by 113
Masugi, Y., Abe, T., Ueno, A., Fujii‐Nishimura, Y., Ojima, H., Endo, Y., Fujita, Y., Kitago, M., Shinoda, M., Kitagawa, Y., et al. (2019) · Modern Pathology · doi:10.1038/s41379-019-0291-z · Cited by 113
Stieber, D., Golebiewska, A., Evers, L., Lenkiewicz, E., Brons, N. H. C., Nicot, N., Oudin, A., Bougnaud, S., Hertel, F., Bjerkvig, R., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1196-4 · Cited by 112
Advancing a clinically relevant perspective of the clonal nature of cancer
Ruiz, C. F., Lenkiewicz, E., Evers, L., Holley, T., Robeson, A., Kiefer, J., Demeure, M. J., Hollingsworth, M. A., Shen, M., Prunkard, D. E., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1104009108 · Cited by 111
Einaga, N., Yoshida, A., Noda, H., Suemitsu, M., Nakayama, Y., Sakurada, A., Kawaji, Y., Yamaguchi, H., Sasaki, Y., Tokino, T., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0176280 · Cited by 117
Perkhofer, L., Schmitt, A., Carrasco, M. C. R., Ihle, M., Hampp, S., Ruess, D. A., Heßmann, E., Russell, R., Lechel, A., Azoitei, N., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0634 · Cited by 113
Microbiota, Oral Microbiome, and Pancreatic Cancer
Michaud, D. S., & Izard, J. (2014) · The Cancer Journal · doi:10.1097/ppo.0000000000000046 · Cited by 115
Blackburn, J. S., Liu, S., Wilder, J. L., Dobrinski, K. P., Lobbardi, R., Moore, F. E., Martinez, S. A., Chen, E. Y., Lee, C., & Langenau, D. M. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.01.032 · Cited by 111
Radiomics in stratification of pancreatic cystic lesions: Machine learning in action
Dalal, V., Carmicheal, J., Dhaliwal, A., Jain, M., Kaur, S., & Batra, S. K. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.10.023 · Cited by 112
Advances in the management of pancreatic cancer
Chiaro, M. D., Sugawara, T., Karam, S. D., & Messersmith, W. A. (2023) · BMJ · doi:10.1136/bmj-2022-073995 · Cited by 118
de Oliveira, R. L., Hamm, A., & Mazzone, M. (2011) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2011.04.001 · Cited by 115
Haage, A., & Schneider, I. C. (2014) · The FASEB Journal · doi:10.1096/fj.13-245613 · Cited by 110
DNA copy number changes define spatial patterns of heterogeneity in colorectal cancer
Mamlouk, S., Childs, L. H., Aust, D. E., Heim, D., Melching, F., de Oliveira, C. M. M., Wolf, T. A., Durek, P., Schumacher, D., Bläker, H., et al. (2017) · Nature Communications · doi:10.1038/ncomms14093 · Cited by 114
Never let it go: Stopping key mechanisms underlying metastasis to fight pancreatic cancer
Giovannetti, E., van der Borden, C. L., Frampton, A. E., Ali, A., Firuzi, O., & Peters, G. J. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.04.006 · Cited by 114
Benešová, L., Belšánová, B., Suchánek, Š., Kopeckova, M., Mináriková, P., Lipská, L., Levý, M., Visokai, V., Zavoral, M., & Minárik, M. (2012) · Analytical Biochemistry · doi:10.1016/j.ab.2012.06.018 · Cited by 109
Hameetman, L., Commandeur, S., Bavinck, J. N. B., Wisgerhof, H. C., de Gruijl, F. R., Willemze, R., Mullenders, L. H. F., Tensen, C. P., & Vrieling, H. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-58 · Cited by 109
Ryu, J. K., Matthaei, H., Molin, M. D., Hong, S., Canto, M. I., Schulick, R. D., Wolfgang, C. L., Goggins, M., Hruban, R. H., Cope, L., et al. (2011) · Pancreatology · doi:10.1159/000329183 · Cited by 109
Self-citationCowin, P. A., George, J., Fereday, S., Loehrer, E. A., Loo, P. V., Cullinane, C. M., Etemadmoghadam, D., Ftouni, S., Galletta, L., Anglesio, M. S., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0203 · Cited by 109
Genome evolution during progression to breast cancerPreprint
Newburger, D. E., Kashef-Haghighi, D., Weng, Z., Salari, R., Sweeney, R. T., Brunner, A. L., Zhu, S., Guo, X., Varma, S., Troxell, M. L., et al. (2013) · Genome Research · doi:10.1101/gr.151670.112 · Cited by 108
Genetic Diversity of Pancreatic Ductal Adenocarcinoma and Opportunities for Precision Medicine
Knudsen, E. S., O'Reilly, E. M., Brody, J. R., & Witkiewicz, A. K. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.08.056 · Cited by 115
MiR-196a Promotes Pancreatic Cancer Progression by Targeting Nuclear Factor Kappa-B-Inhibitor Alpha
Huang, F., Tang, J., Zhuang, X., Zhuang, Y., Cheng, W., Chen, W., Yao, H., & Zhang, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087897 · Cited by 108
Alvergne, A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-08-097086-8.81022-3 · Cited by 108
Inferring Clonal Composition from Multiple Sections of a Breast Cancer
Zare, H., Wang, J., Hu, A. K., Weber, K., Smith, J., Nickerson, D. A., Song, C.-Z., Witten, D., Blau, C. A., & Noble, W. S. (2014) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003703 · Cited by 103
Pancreatic cancer stem cells: features and detection methods
Ishiwata, T., Matsuda, Y., Yoshimura, H., Sasaki, N., Ishiwata, S., Ishikawa, N., Takubo, K., Arai, T., & Aida, J. (2018) · Pathology & Oncology Research · doi:10.1007/s12253-018-0420-x · Cited by 107
Maekawa, T., Fukaya, R., Takamatsu, S., Itoyama, S., Fukuoka, T., Yamada, M., Hata, T., Nagaoka, S., Kawamoto, K., Eguchi, H., et al. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.10.169 · Cited by 106
Transcriptional Heterogeneity of Beta Cells in the Intact Pancreas
Farack, L., Golan, M., Egozi, A., Dezorella, N., Bahar Halpern, K., Ben-Moshe, S., Garzilli, I., Tóth, B., Roitman, L., Krizhanovsky, V., et al. (2019) · Developmental Cell · doi:10.1016/j.devcel.2018.11.001 · Cited by 97
Preclinical models of pancreatic ductal adenocarcinoma
Hwang, C., Boj, S. F., Clevers, H. C., & Tuveson, D. A. (2015) · The Journal of Pathology · doi:10.1002/path.4651 · Cited by 105
Non-invasive biomarkers in pancreatic cancer diagnosis: what we need versus what we have
Herreros‐Villanueva, M., & Bujanda, L. (2016) · Annals of Translational Medicine · doi:10.21037/atm.2016.03.44 · Cited by 102
The hepatic pre-metastatic niche in pancreatic ductal adenocarcinoma
Houg, D. S., & Bijlsma, M. F. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0842-9 · Cited by 114
Overlooking Evolution: A Systematic Analysis of Cancer Relapse and Therapeutic Resistance Research
Aktipis, A., Kwan, V. S. Y., Johnson, K. A., Neuberg, S. L., & Maley, C. C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026100 · Cited by 106
The Temporal Order of Genetic and Pathway Alterations in Tumorigenesis
Gerstung, M., Eriksson, N., Lin, J., Vogelstein, B., & Beerenwinkel, N. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027136 · Cited by 103
Self-citationBeckman, R. A., Schemmann, G. S., & Yeang, C. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1203559109 · Cited by 106
Clinical Applications of Next-Generation Sequencing in Cancer Diagnosis
Sabour, L., Takanlou, M. S., & Ghorbian, . (2016) · Pathology & Oncology Research · doi:10.1007/s12253-016-0124-z · Cited by 108
Novel therapeutic targets for cancer metastasis
Stoletov, K. V., Beatty, P. H., & Lewis, J. D. (2020) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2020.1718496 · Cited by 104
Tumor Heterogeneity in Pancreatic Adenocarcinoma
Cros, J. F., Raffenne, J., Couvelard, A., & Poté, N. (2017) · Pathobiology · doi:10.1159/000477773 · Cited by 106
Li, X., Meng, D., Chen, S., Luo, H., Zhang, Q., Jin, W., & Yan, J. (2017) · Nature Communications · doi:10.1038/s41467-017-00969-8 · Cited by 102
Analysis of cancer genomes reveals basic features of human aging and its role in cancer development
Podolskiy, D. I., Lobanov, A. V., Kryukov, G. V., & Gladyshev, V. N. (2016) · Nature Communications · doi:10.1038/ncomms12157 · Cited by 100
Addressing Genetic Tumor Heterogeneity through Computationally Predictive Combination Therapy
Zhao, B., Pritchard, J. R., Lauffenburger, D. A., & Hemann, M. T. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0465 · Cited by 98
Knudsen, E. S., Balaji, U., Mannakee, B. K., Vail, P. J., Eslinger, C. R., Moxom, C., Mansour, J. C., & Witkiewicz, A. K. (2017) · Gut · doi:10.1136/gutjnl-2016-313133 · Cited by 101
Mascitti, M., Togni, L., Troiano, G., Caponio, V. C. A., Gissi, D. B., Montebugnoli, L., Procaccini, M., Muzio, L. L., & Santarelli, A. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00232 · Cited by 100
Ruze, R., Song, J., Yin, X., Chen, Y., Xu, R., Wang, C., & Zhao, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01376-w · Cited by 111
Impact of delay between imaging and treatment in patients with potentially curable pancreatic cancer
Sanjeevi, S., Ivanics, T., Lundell, L. R., Kartalis, N., Andrén‐Sandberg, Å., Blomberg, J., Chiaro, M. D., & Ansorge, C. (2015) · British journal of surgery · doi:10.1002/bjs.10046 · Cited by 101
PDX1 dynamically regulates pancreatic ductal adenocarcinoma initiation and maintenancePreprint
Roy, N., Takeuchi, K. K., Ruggeri, J. M., Bailey, P., Chang, D., Li, J., Leonhardt, L., Puri, S., Hoffman, M., Gao, S., et al. (2016) · Genes & Development · doi:10.1101/gad.291021.116 · Cited by 98
Understanding genomic alterations in cancer genomes using an integrative network approach
Wang, E. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.11.050 · Cited by 100
Do mutator mutations fuel tumorigenesis?
Fox, E. J., Prindle, M. J., & Loeb, L. A. (2013) · Cancer and Metastasis Reviews · doi:10.1007/s10555-013-9426-8 · Cited by 109
Diabetes and Cancer—An AACE/ACE Consensus Statement
Handelsman, Y., LeRoith, D., Bloomgarden, Z. T., Dagogo-Jack, S. E., EINHORN, D. F., Garber, A. J., Grunberger, G., Harrell, R. M., Gagel, R. F., Lebovitz, H. E., et al. (2013) · Endocrine Practice · doi:10.4158/ep13248.cs · Cited by 100
Clonal evolution of high‐grade serous ovarian carcinoma from primary to recurrent disease
Castellarin, M. L., Milne, K., Zeng, T., Tse, K., Mayo, M., Zhao, Y., Webb, J. R., Watson, P. H., Nelson, B. H., & Holt, R. A. (2012) · The Journal of Pathology · doi:10.1002/path.4105 · Cited by 101
Risk of Cancer in Autoimmune Pancreatitis
Hart, P. A., Law, R. J., Dierkhising, R., Smyrk, T. C., Takahashi, N., & Chari, S. T. (2014) · Pancreas · doi:10.1097/mpa.0000000000000053 · Cited by 98
Wang, Y., Li, Z., Zheng, S., Zhou, Y., Zhao, L., Ye, H., Zhao, X., Gao, W., Fu, Z., Zhou, Q., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5533 · Cited by 98
Therapeutic trends in pancreatic ductal adenocarcinoma (PDAC)
Chandana, S. R., Babiker, H. M., & Mahadevan, D. (2018) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2019.1557145 · Cited by 102
Zhou, M., Hall, L., Goldgof, D., Russo, R., Balagurunathan, Y., Gillies, R., & Gatenby, R. (2014) · Translational Oncology · doi:10.1593/tlo.13730 · Cited by 97
Roper, N., Gao, S., Maity, T. K., Banday, A. R., Zhang, X., Venugopalan, A. K., Cultraro, C. M., Patidar, R., Sindiri, S., Brown, A., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2019.02.028 · Cited by 97
Watanabe, F., Suzuki, K., Tamaki, S., Abe, I., Endo, Y., Takayama, Y., Ishikawa, H., Kakizawa, N., Saito, M., Futsuhara, K., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0227366 · Cited by 100
Tuning Cancer Fate: Tumor Microenvironment's Role in Cancer Stem Cell Quiescence and Reawakening
Sistigu, A., Musella, M., Galassi, C., Vitale, I., & Maria, R. D. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02166 · Cited by 102
RBFOX2 modulates a metastatic signature of alternative splicing in pancreatic cancer
Jbara, A., Lin, K., Stossel, C., Siegfried, Z., Shqerat, H., Amar-Schwartz, A., Elyada, E., Mogilevsky, M., Raitses‐Gurevich, M., Johnson, J. L., et al. (2023) · Nature · doi:10.1038/s41586-023-05820-3 · Cited by 98
The impact of hypoxia in pancreatic cancer invasion and metastasis
Díaz, B., & Yuen, A. (2014) · Hypoxia · doi:10.2147/hp.s52636 · Cited by 101
Masugi, Y., Yamazaki, K., Emoto, K., Effendi, K., Tsujikawa, H., Kitago, M., Itano, O., Kitagawa, Y., & Sakamoto, M. (2015) · Laboratory Investigation · doi:10.1038/labinvest.2014.166 · Cited by 95
Estimating Cancer Latency Times Using a Weibull Model
Nadler, D. L., & Zurbenko, I. G. (2014) · Advances in Epidemiology · doi:10.1155/2014/746769 · Cited by 95
Risk factors for pancreatic cancer: underlying mechanisms and potential targets
Kolodecik, T. R., Shugrue, C., Ashat, M., & Thrower, E. C. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2013.00415 · Cited by 95
Miller, H. C., Drymousis, P., Flora, R., Goldin, R. D., Spalding, D. R. C., & Frilling, A. (2014) · World Journal of Surgery · doi:10.1007/s00268-014-2451-0 · Cited by 94
Nolen, B. M., Brand, R. E., Prosser, D., Velikokhatnaya, L., Allen, P. J., Zeh, H. J., Grizzle, W. E., Lomakin, A., & Lokshin, A. E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094928 · Cited by 94
Bao, Z., Wang, Y., Wang, Q., Fang, S., Shan, X., Wang, J., & Jiang, T. (2021) · Frontiers of Medicine · doi:10.1007/s11684-020-0760-2 · Cited by 93
Nauck, M. A., Jensen, T. J., Rosenkilde, C., Calanna, S., Buse, J. B., & the LEADER Publication Committee on behalf of the LEADER Trial Investigators (2018) · Diabetes Care · doi:10.2337/dc17-1825 · Cited by 94
NF-κB as a target for pancreatic cancer therapy
Carbone, C., & Melisi, D. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.645806 · Cited by 93
Relationship between tumour size and outcome in pancreatic ductal adenocarcinoma
Ansari, D., Bauden, M. P., Bergström, S., Rylance, R. T., Marko‐Varga, G., & Andersson, R. E. (2017) · British journal of surgery · doi:10.1002/bjs.10471 · Cited by 93
Hao, L., Zeng, X., Xin, L., Wang, D., Pan, J., Bi, Y., Ji, J., Du, T., Lin, J., Zhang, D., et al. (2017) · Digestive and Liver Disease · doi:10.1016/j.dld.2017.07.001 · Cited by 93
Werner, R. A., Ilhan, H., Lehner, S., Papp, L., Zsótér, N., Schatka, I., Muegge, D. O., Javadi, M. S., Higuchi, T., Buck, A. K., et al. (2018) · Molecular Imaging and Biology · doi:10.1007/s11307-018-1252-5 · Cited by 93
Clinical translation of patient-derived tumour organoids- bottlenecks and strategies
Foo, M. A., You, M., Chan, S. L., Sethi, G., Bonney, G. K., Yong, W. P., Chow, E. K., Fong, E. L. S., Wang, L., & Goh, B.-C. (2022) · Biomarker Research · doi:10.1186/s40364-022-00356-6 · Cited by 100
Zhang, Q. H., Ubago, J. M., Li, L., Guo, H., Liu, Y., Qiang, W., Kim, J. J., Kong, B., & Wei, J. (2014) · Cancer · doi:10.1002/cncr.28900 · Cited by 93
Baicalein - An Intriguing Therapeutic Phytochemical in Pancreatic Cancer
Donald, G. W., Hertzer, K. M., & Eibl, G. (2012) · Current Drug Targets · doi:10.2174/138945012804545470 · Cited by 93
Heterogeneity and Tumor History
Shibata, D. K. (2012) · Science · doi:10.1126/science.1222361 · Cited by 93
Genetics of familial and sporadic pancreatic cancer
Wood, L. D., Yurgelun, M. B., & Goggins, M. G. (2019) · Gastroenterology · doi:10.1053/j.gastro.2018.12.039 · Cited by 91
Werner‐Klein, M., Scheitler, S., Hoffmann, M., Hodak, I., Dietz, K., Lehnert, P., Naimer, V., Polzer, B. M., Treitschke, S., Werno, C., et al. (2018) · Nature Communications · doi:10.1038/s41467-017-02674-y · Cited by 91
How to Make Anticancer Drugs Cross the Blood–Brain Barrier to Treat Brain Metastases
Angeli, E., Nguyen, T. T., Janin, A., & Bousquet, G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms21010022 · Cited by 93
Tumour-wide RNA splicing aberrations generate actionable public neoantigens
Kwok, D. W., Stevers, N. O., Etxeberría, I., Nejo, T., Cove, M. C., Chen, L. H., Jung, J., Okada, K., Lakshmanachetty, S., Gallus, M., et al. (2025) · Nature · doi:10.1038/s41586-024-08552-0 · Cited by 107
Lee, J., Yoon, J.-K., Kim, B., Kim, S., Kim, M. A., Lim, H., Bang, D., & Song, Y. S. (2015) · BMC Cancer · doi:10.1186/s12885-015-1077-4 · Cited by 90
Concepts of metastasis in flux: The stromal progression model
Sleeman, J. P., Christofori, G., Fodde, R., Collard, J. G., Berx, G., Decraene, C., & Rüegg, C. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.02.007 · Cited by 90
Radical Irradiation of Extracranial Oligometastases
Salama, J. K., & Milano, M. T. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.55.9567 · Cited by 90
Identification of Ovarian Cancer Metastatic miRNAs
Vang, S., Wu, H.-T., Fischer, A. K., Miller, D. H., MacLaughlan, S. D., Douglass, E. M., Steinhoff, M. M., Collins, C. C., Smith, P. J., Brard, L., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058226 · Cited by 90
Single-cell analysis can define distinct evolution of tumor sites in follicular lymphoma
Haebe, S., Shree, T., Sathe, A., Day, G., Czerwinski, D. K., Grimes, S. M., Lee, H., Binkley, M. S., Long, S., Martin, B. A., et al. (2021) · Blood · doi:10.1182/blood.2020009855 · Cited by 95
Inamura, K., Hamada, T., Bullman, S., Ugai, T., Yachida, S., & Ogino, S. (2022) · Gut · doi:10.1136/gutjnl-2022-327209 · Cited by 97
Self-citationHypoxia and Regulation of Cancer Cell Stemness
Yun, Z., & Lin, Q. (2013) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-5915-6_2 · Cited by 92
Dimastromatteo, J., Brentnall, T. A., & Kelly, K. A. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.144 · Cited by 92
Zhang, X. C., Xu, C., Mitchell, R. M., Zhang, B., Zhao, D., Li, Y., Huang, X. H., Fan, W., Wang, H., Lerma, L. A., et al. (2013) · Neoplasia · doi:10.1593/neo.131400 · Cited by 89
Glassman, D. C., Palmaira, R. L. D., Covington, C. M., Desai, A. M., Ku, G. Y., Li, J., Harding, J. J., Varghese, A. M., O'Reilly, E. M., & Yu, K. H. (2018) · BMC Cancer · doi:10.1186/s12885-018-4605-1 · Cited by 89
Katagiri, R., Goto, A., Nakagawa, T., Nishiumi, S., Kobayashi, T., Hidaka, A., Budhathoki, S., Yamaji, T., Sawada, N., Shimazu, T., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.07.033 · Cited by 89
Intra‐tumour heterogeneity – going beyond genetics
Caiado, F., Silva‐Santos, B., & Norell, H. (2016) · FEBS Journal · doi:10.1111/febs.13705 · Cited by 87
Epigenetic biomarkers in gastrointestinal cancers: The current state and clinical perspectives
Vedeld, H. M., Goel, A., & Lind, G. E. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.12.004 · Cited by 86
Pancreatic tumor cell metabolism: Focus on glycolysis and its connected metabolic pathways
Guillaumond, F., Iovanna, J., & Vasseur, S. (2014) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2013.12.019 · Cited by 90
Alam, M. M., Lal, S., FitzGerald, K. E., & Li, Z. (2016) · Clinical and Translational Medicine · doi:10.1186/s40169-016-0082-9 · Cited by 92
Large, T. Y. S. L., Bijlsma, M. F., Geert Kazemier, M., van Laarhoven, H. W. M., Giovannetti, E., & Jiménez, C. R. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.03.008 · Cited by 93
Targeted Therapies for Pancreatic Cancer and Hurdles Ahead
Aslan, M., Shahbazi, R., Ulubayram, K., & Özpolat, B. (2018) · Anticancer Research · doi:10.21873/anticanres.13026 · Cited by 92
Cancer biology as revealed by the research autopsy
Iacobuzio–Donahue, C. A., Michael, C., Baez, P., Kappagantula, R. L., Hooper, J. E., & Hollman, T. J. (2019) · Nature reviews. Cancer · doi:10.1038/s41568-019-0199-4 · Cited by 89
Self-citationMapping genomic and epigenomic evolution in cancer ecosystems
Ushijima, T., Clark, S. J., & Tan, P. B. O. (2021) · Science · doi:10.1126/science.abh1645 · Cited by 89
Tang, Q., Moore, J. C., Ignatius, M. S., Tenente, I. M., Hayes, M. N., Garcia, E. G., Yordán, N. T., Bourque, C., He, S., Blackburn, J. S., et al. (2016) · Nature Communications · doi:10.1038/ncomms10358 · Cited by 91
Cellular determinants and therapeutic implications of inflammation in pancreatic cancer
Stone, M. L., & Beatty, G. L. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.05.012 · Cited by 87
Pathology of pancreatic ductal adenocarcinoma: Facts, challenges and future developments
Esposito, I. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i38.13833 · Cited by 95
Serrão, E. M., Kettunen, M. I., Rodrigues, T. B., Dzien, P., Wright, A. J., Gopinathan, A., Gallagher, F. A., Lewis, D. Y., Frese, K. K., Almeida, J., et al. (2015) · Gut · doi:10.1136/gutjnl-2015-310114 · Cited by 87
Metadata
- Authors
- Yachida, S., Jones, S., Bozic, I., Antal, T., Leary, R., Fu, B., Kamiyama, M., Hruban, R. H., Eshleman, J. R., Nowak, M. A., Velculescu, V. E., Kinzler, K. W., Vogelstein, B., & Iacobuzio-Donahue, C. A.
- Affiliations
- Johns Hopkins University (US)
- Howard Hughes Medical Institute (US)
- Harvard University (US)
- ORCID
- Venue
- Nature
- Published
- 2010-10
- Volume
- 467
- Issue
- 7319
- Pages
- 1114-1117
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3148940
- OpenAlex
- W2169895148
- Cited by
- 2,502
- References
- 24
- Citations by year
- 2026: 73 · 2025: 84 · 2024: 76 · 2023: 105 · 2022: 122 · 2021: 165 · 2020: 157 · 2019: 147 · 2018: 176 · 2017: 218 · 2016: 208 · 2015: 237 · 2014: 224 · 2013: 182 · 2012: 197
- FWCI
- 50.92
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institutes of Health (5r01ca121113-15)
- U.S. Public Health Service (A62924)
- National Cancer Institute (R01CA140599, CA 57345, R01-CA121113, CA-121113, CA43460, K08CA106610, R37CA043460, R01CA057345, CA106610, P50CA062924, R37CA057345)
- National Institute of General Medical Sciences (R01GM078986, GM078986)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- pancreatic cancer, distant metastasis, clonal evolution, tumor subclones, chromosomal rearrangements, genomic instability, early detection, tumor heterogeneity, therapeutic target
- MeSH terms
- Adenocarcinoma, Autopsy, Clone Cells, DNA Mutational Analysis, Humans, Liver Neoplasms, Lung Neoplasms, Models, Biological, Mutation, Neoplasm Metastasis, Pancreas, Pancreatic Neoplasms, Peritoneal Neoplasms, Time Factors, Disease Progression, Cell Lineage, Evolution, Molecular, Early Detection of Cancer
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
